| pubmed-article:2973666 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0005821 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C1306889 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0005286 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0032183 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:2973666 | lifeskim:mentions | umls-concept:C0332173 | lld:lifeskim |
| pubmed-article:2973666 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2973666 | pubmed:dateCreated | 1988-12-27 | lld:pubmed |
| pubmed-article:2973666 | pubmed:abstractText | In this study we investigated the influence of low-dose (100 mg daily) acetylsalicylic acid (ASA) on 111-In-platelet survival time (PST) and on plasma levels of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in 30 patients (median age: 60 years) with arteriographically proven peripheral arterial occlusive disease in a chronic stable phase. We observed no significant changes of PST during therapy with ASA (weighted mean: 169.8----166 [median] hours; multiple hit: 168.3----170.6 hours), and also the plasma levels of beta-TG (median: 31.8----32.3 ng/ml) and of PF 4 (3.6----3.9 ng/ml) remained unchanged. | lld:pubmed |
| pubmed-article:2973666 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2973666 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2973666 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2973666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2973666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2973666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2973666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2973666 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2973666 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:2973666 | pubmed:issn | 0049-3848 | lld:pubmed |
| pubmed-article:2973666 | pubmed:author | pubmed-author:JungMM | lld:pubmed |
| pubmed-article:2973666 | pubmed:author | pubmed-author:EhringerHH | lld:pubmed |
| pubmed-article:2973666 | pubmed:author | pubmed-author:MinarEE | lld:pubmed |
| pubmed-article:2973666 | pubmed:author | pubmed-author:Koppensteiner... | lld:pubmed |
| pubmed-article:2973666 | pubmed:author | pubmed-author:StümpflenAA | lld:pubmed |
| pubmed-article:2973666 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2973666 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:2973666 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:2973666 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2973666 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2973666 | pubmed:pagination | 219-26 | lld:pubmed |
| pubmed-article:2973666 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:meshHeading | pubmed-meshheading:2973666-... | lld:pubmed |
| pubmed-article:2973666 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2973666 | pubmed:articleTitle | Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. | lld:pubmed |
| pubmed-article:2973666 | pubmed:affiliation | Department of Angiology, I. Medical University Clinic, Vienna, Austria. | lld:pubmed |
| pubmed-article:2973666 | pubmed:publicationType | Journal Article | lld:pubmed |
